Stories
Maxivision Eye Hospitals Confidentially Files for IPO, Takes First Step Towards Listing
- •Maxivision Super Specialty Eye Hospitals, backed by Quadria Capital, has confidentially filed for an initial public offering.
- •Reuters previously reported that ICICI Securities and IIFL Capital were appointed as bankers for the IPO, which will include new shares and existing investor stock.
- •India's confidential filing mechanism allows companies to submit draft IPO papers privately to the market regulator.
- •Founded in 1996, Maxivision operates over 90 centers across six states, competing with Dr. Agarwal's Health Care, Centre for Sight, and ASG Eye Hospitals.
- •India's eye-care market is projected to grow significantly, from $12.8 billion in 2025 to $31.2 billion by 2033.
Key Questions Answered
Maxivision Eye Hospitals has confidentially filed for an initial public offering, marking its first formal step toward a stock listing. The offering includes a mix of newly issued shares and stock sold by existing investors, with ICICI Securities and IIFL Capital appointed as bankers.
India's confidential filing mechanism permits companies to submit draft IPO papers to the market regulator without making them public. This keeps financial and operational details private while the company seeks regulatory approval.
Founded in 1996, Maxivision operates more than 90 centres across six states and is backed by the healthcare-focused buyout firm Quadria Capital. It competes with major chains like Dr. Agarwal's Health Care, Centre for Sight, and ASG Eye Hospitals.
